Stockscreener 앱 받기
27.51
0.43%
-0.12
시간 외 거래:
27.51
전일 마감가:
$27.63
열려 있는:
$27.73
하루 거래량:
612.86K
Relative Volume:
0.14
시가총액:
$1.71B
수익:
$14.34M
순이익/손실:
$-199.00M
주가수익비율:
-7.0179
EPS:
-3.92
순현금흐름:
$-183.51M
1주 성능:
-1.08%
1개월 성능:
-60.70%
6개월 성능:
+82.91%
1년 성능:
+356.98%
1일 변동 폭
$26.77
$27.90
1주일 범위
$26.76
$29.99
52주 변동 폭
$5.89
$71.50
Uniqure N V Stock (QURE) Company Profile
명칭
Uniqure N V
전화
1-339-970-7000
주소
PAASHEUVELWEG 25A, AMSTERDAM
QURE을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
QURE
Uniqure N V
|
27.51 | 1.72B | 14.34M | -199.00M | -183.51M | -3.92 |
|
VRTX
Vertex Pharmaceuticals Inc
|
433.61 | 109.65B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
780.19 | 82.46B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
451.23 | 58.81B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
911.98 | 56.50B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
207.77 | 43.62B | 447.02M | -1.18B | -906.14M | -6.1812 |
Uniqure N V Stock (QURE) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-11-04 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2025-08-14 | 업그레이드 | Mizuho | Neutral → Outperform |
| 2025-04-01 | 재개 | Chardan Capital Markets | Buy |
| 2024-12-10 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2024-10-10 | 재개 | Raymond James | Outperform |
| 2024-02-29 | 다운그레이드 | Goldman | Buy → Neutral |
| 2023-12-19 | 다운그레이드 | Mizuho | Buy → Neutral |
| 2022-03-17 | 업그레이드 | UBS | Neutral → Buy |
| 2021-06-15 | 개시 | BTIG Research | Buy |
| 2021-05-21 | 개시 | UBS | Neutral |
| 2021-04-26 | 재개 | Credit Suisse | Outperform |
| 2021-04-01 | 업그레이드 | Mizuho | Neutral → Buy |
| 2021-01-07 | 업그레이드 | Guggenheim | Neutral → Buy |
| 2020-11-24 | 개시 | H.C. Wainwright | Buy |
| 2020-11-11 | 개시 | Berenberg | Buy |
| 2020-11-09 | 개시 | Jefferies | Buy |
| 2020-11-04 | 개시 | Cantor Fitzgerald | Overweight |
| 2020-10-23 | 개시 | RBC Capital Mkts | Outperform |
| 2020-08-25 | 개시 | Raymond James | Strong Buy |
| 2020-07-31 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2020-06-25 | 다운그레이드 | Mizuho | Buy → Neutral |
| 2020-06-25 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2020-06-25 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2019-12-03 | 개시 | Cowen | Outperform |
| 2019-12-03 | 개시 | Goldman | Buy |
| 2019-11-05 | 개시 | Credit Suisse | Outperform |
| 2019-10-11 | 개시 | Stifel | Buy |
| 2019-09-25 | 개시 | Bernstein | Outperform |
| 2019-09-12 | 개시 | Mizuho | Buy |
| 2019-07-30 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2019-07-08 | 재확인 | Cantor Fitzgerald | Overweight |
| 2019-04-12 | 개시 | Piper Jaffray | Overweight |
| 2019-03-29 | 개시 | Robert W. Baird | Outperform |
모두보기
Uniqure N V 주식(QURE)의 최신 뉴스
How sustainable is uniQure N.V. stock dividend payoutJuly 2025 Opening Moves & Stepwise Trade Signal Guides - moha.gov.vn
Market Pulse: Can uniQure N.V. stock surprise with earnings upsideWeekly Investment Report & Technical Entry and Exit Tips - moha.gov.vn
How uniQure N.V. stock benefits from tech adoptionJuly 2025 Trade Ideas & Reliable Breakout Stock Forecasts - moha.gov.vn
uniQure put volume heavy and directionally bearish - TipRanks
uniQure (QURE) Is Down 5.9% After FDA Calls AMT-130 Data Insufficient for BLA Approval – Has the Bull Case Changed? - simplywall.st
uniQure is Now Oversold (QURE) - Nasdaq
William Blair Maintains Market Perform Rating on uniQure (QURE) Despite AMT-130 Approval Uncertainty - MSN
Certain Performance Stock of uniQure N.V. are subject to a Lock-Up Agreement Ending on 25-NOV-2025. - MarketScreener
Certain Options of uniQure N.V. are subject to a Lock-Up Agreement Ending on 25-NOV-2025. - MarketScreener
Certain Ordinary Shares of uniQure N.V. are subject to a Lock-Up Agreement Ending on 25-NOV-2025. - MarketScreener
QURE Investigation Alert: Kessler Topaz Meltzer & Check, - GlobeNewswire
QURE Investigation Alert: Kessler Topaz Meltzer & Check, LLP Encourages uniQure N.V. (NASDAQ: QURE) Investors with Significant Losses to Contact the Firm - GlobeNewswire Inc.
A significant driver of top-line growth: uniQure N.V (QURE) - Setenews
9 Oversold Biotech Stocks to Invest In - Insider Monkey
uniQure NV Faces Weak Start with 5.08% Gap Down Amid Market Concerns - Markets Mojo
QURE Investigation Notification: Kessler Topaz Meltzer & Check, LLP Encourages uniQure N.V. (NASDAQ: QURE) Investors with Significant Losses to Contact the Firm - Eastern Progress
uniQure (NASDAQ:QURE) Downgraded by Wall Street Zen to “Sell” - Defense World
(QURE) Movement as an Input in Quant Signal Sets - news.stocktradersdaily.com
QURE Investigation Reminder: Kessler Topaz Meltzer & Check, LLP Encourages uniQure N.V. (NASDAQ: QURE) Investors With Significant Losses to Contact the Firm - NewMediaWire
Why uniQure N.V. (UQ1) stock is trending on social mediaJuly 2025 Breakouts & AI Optimized Trade Strategies - newser.com
How currency fluctuations impact uniQure N.V. stock - newser.com
Is uniQure N.V. stock a buy on dipsTrade Analysis Report & Daily Volume Surge Signals - newser.com
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of uniQure N.V.QURE - PR Newswire
Will uniQure N.V. stock deliver shareholder valueJuly 2025 Price Swings & Reliable Breakout Forecasts - newser.com
Is uniQure N.V. (UQ1) stock supported by strong fundamentals - newser.com
Reviewing uniQure (NASDAQ:QURE) and Biogen (NASDAQ:BIIB) - Defense World
Published on: 2025-11-19 17:01:52 - newser.com
Can uniQure N.V. stock hit record highs againTrade Volume Summary & Risk Controlled Stock Pick Alerts - newser.com
Predicting uniQure N.V. trend using moving averagesJuly 2025 PreEarnings & Reliable Intraday Trade Alerts - newser.com
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against uniQure N.V. (QURE) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
uniQure N.V. (QURE) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
QURE Investigation: Kessler Topaz Meltzer & Check, LLP Encourages uniQure N.V. (NASDAQ: QURE) Investors With Significant Losses to Contact the Firm - FinancialContent
Wall Street Has a Positive Outlook on uniQure N.V. (QURE) Despite Challenges From The FDA - MSN
Summers Value Partners Established a Position in UniQure N.V. (QURE) in Q3 - Insider Monkey
Can uniQure N.V. (UQ1) stock sustain revenue momentumQuarterly Earnings Summary & Detailed Earnings Play Strategies - newser.com
Can uniQure N.V. stock hit analyst price targetsTrade Risk Report & Safe Entry Point Identification - newser.com
Volatility clustering patterns for uniQure N.V.Gold Moves & Real-Time Chart Breakout Alerts - newser.com
Is uniQure N.V. stock a bargain at current levelsPortfolio Performance Report & Daily Volume Surge Signals - newser.com
uniQure N.V. Investigation: Kessler Topaz Meltzer & Check, LLP Encourages uniQure N.V. (NASDAQ: QURE) Investors With Significant Losses to Contact the Firm - NewMediaWire
uniQure NV Faces Weak Start with 10.32% Gap Down Amid Market Concerns - Markets Mojo
Do Rising Losses at uniQure (QURE) Reflect Strategic Investment or Escalating Cost Pressure? - simplywall.st
Uniqure N V (QURE) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.45%
1.13%
자본화:
|
볼륨(24시간):